Clinical Presentation of Hypersensitivity Pneumonitis
Hypersensitivity pneumonitis presents in two major clinical forms—nonfibrotic and fibrotic—with distinct symptom patterns, imaging findings, and prognostic implications that require different diagnostic and management approaches. 1
Nonfibrotic (Acute/Subacute) Presentation
Clinical Symptoms
The nonfibrotic form typically manifests with:
- Dyspnea and cough as the predominant respiratory symptoms 2
- Fever is characteristic and significantly more common in acute presentations (p < 0.001) 2
- Symptoms often have a temporal relationship with antigen exposure 3, 4
- Episodes may be recurrent with repeated exposures 1
Imaging Characteristics on HRCT
The hallmark imaging features include 1:
Typical nonfibrotic HP pattern:
- Profuse, poorly defined centrilobular nodules of ground-glass opacity affecting all lung zones (highly suggestive in nonsmokers)
- Inspiratory mosaic attenuation with three-density sign (formerly "headcheese sign")
- Mosaic attenuation and air-trapping associated with centrilobular nodules
Compatible with nonfibrotic HP:
- Centrilobular nodules that are not profuse or diffuse
- Patchy or diffuse ground-glass opacity
- Mosaic attenuation and lobular air-trapping without centrilobular nodules
Ground-glass opacities are statistically more common in acute/subacute presentations (p = 0.002) 2.
Laboratory Findings
- Elevated BAL lymphocytes (typically >22% in acute forms) 1
- Lowest CD4/CD8 ratio in acute forms (p = 0.001) 2
- Diffuse lymphocytic infiltration on transbronchial biopsy when performed 1
Fibrotic (Chronic) Presentation
Clinical Symptoms
The fibrotic form presents with:
- Insidious onset over months to years with progressive dyspnea 1, 3
- No history of acute episodes in many cases (the "insidious" subtype) 1
- Dyspnea and cough remain predominant, but fever is uncommon 2
- Symptoms may be chronic and slowly progressive without clear temporal relationship to exposure 1
Critical pitfall: Symptom duration and type do NOT predict survival or disease severity in fibrotic HP 1. The presence of fibrosis on imaging is the key prognostic determinant.
Imaging Characteristics on HRCT
Fibrotic HP requires both fibrosis AND small airway disease features 5:
Typical fibrotic HP pattern:
- Irregular linear opacities/coarse reticulation with lung distortion
- Traction bronchiectasis (honeycombing may be present but does not predominate)
- Distribution patterns suggestive of HP:
- Random both axially and craniocaudally
- Mid-lung zone predominant (highly suggestive)
- Upper lobe predominance (more common than in IPF)
- Relatively spared lower lung zones
Plus at least one small airway disease feature:
- Ill-defined centrilobular nodules and/or ground-glass opacities
- Mosaic attenuation, three-density pattern, and/or air-trapping (lobular distribution)
Reticulation is statistically more common in chronic forms (p < 0.001) 2.
Prognostic Implications
Fibrosis on HRCT is the most critical prognostic factor 1:
- Fibrotic HP patients have 4.35 times increased risk of death compared to nonfibrotic HP (HR 4.35; 95% CI 2.22-8.33) 1
- Pulmonary fibrosis is associated with shortened survival (HR 6.99; 95% CI 1.34-61.92) after adjusting for confounders 1
- Honeycombing confers the worst prognosis, with patients surviving less than those with non-honeycomb fibrosis (HR 0.26; 95% CI 0.12-0.54) 1
- The extent of fibrosis (fibrosis score) independently predicts time to death or lung transplantation (HR 1.54; 95% CI 1.25-1.88) 1
Key Diagnostic Distinctions
Overlap and Mimicry
A major diagnostic challenge is that fibrotic HP can mimic other interstitial lung diseases 3, 4:
- May resemble usual interstitial pneumonia (UIP)/idiopathic pulmonary fibrosis
- Can appear similar to nonspecific interstitial pneumonia (NSIP)
- May overlap with organizing pneumonia patterns
The presence of small airway disease features (centrilobular nodules, mosaic attenuation, air-trapping) alongside fibrosis is the key distinguishing feature that points toward HP rather than other fibrotic ILDs 5.
Laboratory Support
- BAL lymphocytes may be lower in fibrotic forms compared to acute presentations, though still often elevated 2
- Antigen identification is critical for diagnosis and prognosis—unidentified antigen exposure trends toward worse survival (HR 2.07; 95% CI 1.02-4.24) 1
Clinical Heterogeneity
Important caveat: There is significant overlap between acute, subacute, and chronic forms 3. The current classification into nonfibrotic versus fibrotic is more clinically relevant than the traditional acute/subacute/chronic terminology, as it directly impacts prognosis and treatment decisions 1.
Mosaic attenuation, while frequently observed across all forms, shows no statistically significant difference between acute and chronic presentations (p = 0.512) 2, emphasizing that small airway involvement is a unifying feature across the HP spectrum.